Transcriptional elongation machinery controls vulnerability of breast cancer cells to PRC2 inhibitors

Ngai Ting Chan(University of Wisconsin–Madison), Wei Xu(University of Wisconsin–Madison)

bioRxiv (Cold Spring Harbor Laboratory)

January 8, 2020

10.1101/2020.01.08.898577

Cited by 0

Related Papers

Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition

|Nature Communications|2017|138

Systematic Analyses of the Cytotoxic Effects of Compound 11a, a Putative Synthetic Agonist of Photoreceptor-Specific Nuclear Receptor (PNR), in Cancer Cell Lines

|PLoS ONE|2013|12

<scp><i>NEAT1</i></scp> repression by <scp>MED12</scp> creates chemosensitivity in p53 wild‐type breast cancer cells

|FEBS Journal|2024|6

Modeling high-risk Wilms tumors enables the discovery of therapeutic vulnerability

|Cell Reports Medicine|2024|6